Hello and Welcome to Patientsville.com, Your Source for all KARVEA information. We are dedicated to provide You with KARVEA safety information. Learn about KARVEA serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
KARVEA Safety Reports
Total KARVEA reports: 15.KARVEA FDA safety alerts: No.
Reported hospitalizations: 8.
Take KARVEA Side Effects Survey or Share Your KARVEA Story. Read More Here.
Consumer or non-health professional from ITALY reported KARVEA problem on May 15, 2007. Female patient, 86 years of age, was diagnosed with hypertension, cardiac failure, atrial fibrillation and was treated with KARVEA. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, bradycardia, hyperkalaemia. KARVEA dosage: unknown. During the same period patient was treated with ALDACTONE, DIGOXIN, LASIX, COUMADIN, FENOFIBRATE. Patient was hospitalized. Patient recovered.
KARVEA problem was reported by a Consumer or non-health professional from ITALY on May 23, 2007. Female patient, 86 years of age, was diagnosed with hypertension, cardiac failure, atrial fibrillation and was treated with KARVEA. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, atrial fibrillation, bradycardia, cardiomyopathy, escherichia urinary tract infection, hyperkalaemia, renal failure acute, therapeutic agent toxicity. KARVEA dosage: unknown. During the same period patient was treated with ALDACTONE, DIGOXIN, LASIX, COUMADIN, FENOFIBRATE. Patient was hospitalized. Patient recovered.
Physician from SPAIN reported KARVEA problem on May 29, 2006. Female patient, 64 years of age, weighting 180.8 lb, was diagnosed with hypertension, pain and was treated with KARVEA. After drug was administered, patient experienced the following problems/side effects: back pain, myalgia. KARVEA dosage: unknown. During the same period patient was treated with PARACETAMOL. Patient recovered.
KARVEA problem was reported by a Health Professional from GERMANY on June 08, 2006. Male patient, 63 years of age, weighting 222.7 lb, was diagnosed with portal hypertension and was treated with KARVEA. After drug was administered, patient experienced the following problems/side effects: bleeding varicose vein, mallory-weiss syndrome. KARVEA dosage: STEP-UP TITRATED UP TO 300 MG/D. During the same period patient was treated with PROPRANOLOL. Patient was hospitalized. Patient recovered.
Physician from GREECE reported KARVEA problem on Sept 01, 2006. Male patient, 68 years of age, was diagnosed with hypertension and was treated with KARVEA. After drug was administered, patient experienced the following problems/side effects: duodenitis, gastric haemorrhage, gastric ulcer, melaena. KARVEA dosage: unknown. During the same period patient was treated with HYGROTON, BETASERC, NOOTROP, VITAMINS. Patient recovered.
KARVEA problem was reported by a Health Professional from AUSTRALIA on Oct 05, 2006. Female patient, 85 years of age, was treated with KARVEA. After drug was administered, patient experienced the following problems/side effects: hyponatraemia, syncope. KARVEA dosage: unknown. During the same period patient was treated with NORVASC, CELEBREX, CALTRATE, IMDUR, LEVOTHYROXINE, ATENOLOL, PROGOUT, SOLPRIN. Patient was hospitalized. Patient recovered.
Physician from AUSTRALIA reported KARVEA problem on Oct 04, 2006. Female patient, 40 years of age, was treated with KARVEA. After drug was administered, patient experienced the following problems/side effects: grand mal convulsion. KARVEA dosage: unknown. During the same period patient was treated with ARAVA, ACTONEL, PREDNISONE, MOBIC. Patient recovered.
KARVEA problem was reported by a Health Professional from AUSTRALIA on Oct 16, 2006. Male patient, 45 years of age, was diagnosed with essential hypertension, diabetes mellitus and was treated with KARVEA. After drug was administered, patient experienced the following problems/side effects: angioneurotic oedema, swollen tongue. KARVEA dosage: unknown. During the same period patient was treated with COVERSYL PLUS, DIABEX. Patient was hospitalized. Patient recovered.
Physician from AUSTRALIA reported KARVEA problem on Oct 04, 2006. Female patient, 40 years of age, was diagnosed with rheumatoid arthritis, osteoporosis and was treated with KARVEA. After drug was administered, patient experienced the following problems/side effects: grand mal convulsion. KARVEA dosage: unknown. During the same period patient was treated with ARAVA, ACTONEL, PREDNISONE, MOBIC. Patient was hospitalized. Patient recovered.
KARVEA problem was reported by a Consumer or non-health professional from AUSTRALIA on Oct 24, 2006. Male patient, 99 years of age, was diagnosed with essential hypertension, arrhythmia, pain in extremity, depression, prostate cancer, bone disorder and was treated with KARVEA. After drug was administered, patient experienced the following problems/side effects: angioneurotic oedema, peripheral ischaemia. KARVEA dosage: unknown. During the same period patient was treated with COUMADIN, BENADRYL, LEXAPRO, SOLGAR, LUCRIN, NORVASC, ROCALTROL, XALATAN. Patient recovered.
Consumer or non-health professional from AUSTRALIA reported KARVEA problem on Nov 09, 2006. Female patient, 59 years of age, was diagnosed with hypertension and was treated with KARVEA. After drug was administered, patient experienced the following problems/side effects: angioneurotic oedema, pruritus. KARVEA dosage: unknown. Patient was hospitalized. Patient recovered.
KARVEA problem was reported by a Consumer or non-health professional from AUSTRALIA on Nov 09, 2006. Female patient, 52 years of age, weighting 130.1 lb, was diagnosed with essential hypertension and was treated with KARVEA. After drug was administered, patient experienced the following problems/side effects: pancreatitis. KARVEA dosage: unknown. Patient recovered.
Health Professional from AUSTRALIA reported KARVEA problem on Dec 05, 2006. Male patient, 40 years of age, was treated with KARVEA. After drug was administered, patient experienced the following problems/side effects: aggression, depression, suicide attempt. KARVEA dosage: unknown. Patient recovered.
KARVEA problem was reported by a Consumer or non-health professional from AUSTRALIA on Dec 05, 2006. Male patient, 45 years of age, weighting 202.8 lb, was treated with KARVEA. After drug was administered, patient experienced the following problems/side effects: suicidal ideation. KARVEA dosage: unknown. Patient recovered.
Health Professional from SPAIN reported KARVEA problem on June 29, 2007. Male patient, 60 years of age, weighting 165.3 lb, was treated with KARVEA. After drug was administered, patient experienced the following problems/side effects: hyperkalaemia, hyponatraemia. KARVEA dosage: unknown. During the same period patient was treated with COTRIM. Patient was hospitalized. Patient recovered.